Mars CEO gets board role at GLP-1 supplier Novo Nordisk [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Poul Weihrauch is to be a “board observer” at the pharma group, which markets GLP-1 drugs under brands including Ozempic and Wegovy. GLP-1 medication, associated with appetite suppression, was first approved to treat Type-2 diabetes in the US more than 15 years ago and for the treatment of obesity around a decade ago. However, with more consumers turning to the drugs to manage their weight, its impact on purchasing behaviour is being closely watched by the food and beverage sectors. Some industry watchers believe the rising use of GLP-1 medication will have a “structural” impact on the market . Research in the US has suggested demand from users for sweet and savoury snacks has been affected. Amid the growing consumer interest in the drugs, food and drinks manufacturers and retailers are weighing up their impact on their sales and how to offer different types of products as users' appetites change. Asked why Novo Nordisk had appointed Weihrauch to the position of board observe
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Assessing Novo Nordisk (NYSE:NVO) Valuation After Recent Weak Share Performance [Yahoo! Finance]Yahoo! Finance
- Obesity drugmaker Kailera plans an IPO [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk (NVO) Shares Up Since Jim Cramer Said He Was A Buyer [Yahoo! Finance]Yahoo! Finance
- Stocks, sectors, and charts this strategist is watching [Yahoo! Finance]Yahoo! Finance
- 1 Reason This Biotech Stock Could Triple Before Year-End [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website